Amortization of Intangible Assets of Evofem Biosciences, Inc. from 30 Sep 2024 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Evofem Biosciences, Inc. quarterly and annual Amortization of Intangible Assets in USD history and change rate from 30 Sep 2024 to 30 Sep 2025.
  • Evofem Biosciences, Inc. Amortization of Intangible Assets for the quarter ending 30 Sep 2025 was $80,000, a 73% decline year-over-year.
Source SEC data
View on sec.gov
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (USD)

Evofem Biosciences, Inc. Quarterly Amortization of Intangible Assets (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $80,000 -$221,000 -73% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $107,000 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $223,000 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q3 2024 $301,000 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3

Evofem Biosciences, Inc. Annual Amortization of Intangible Assets (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $619,000 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.